2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of …

N Galiè, M Humbert, JL Vachiery, S Gibbs… - European heart …, 2016 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

[PDF][PDF] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

N Galiè, M Humbert, JL Vachiery… - Polish Heart …, 2015 - journals.viamedica.pl
6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European …

N Galiè, MM Hoeper, M Humbert, A Torbicki… - European heart …, 2009 - academic.oup.com
Thus, the task of writing Guidelines or Expert Consensus documents covers not only the
integration of the most recent research, but also the creation of educational tools and …

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation task force on expert consensus …

Writing Committee Members, VV McLaughlin… - Circulation, 2009 - Am Heart Assoc
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension | Circulation Science
Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest …

Updated clinical classification of pulmonary hypertension

G Simonneau, IM Robbins, M Beghetti… - Journal of the American …, 2009 - jacc.org
The aim of a clinical classification of pulmonary hypertension (PH) is to group together
different manifestations of disease sharing similarities in pathophysiologic mechanisms …

Pulmonary arterial hypertension in France: results from a national registry

M Humbert, O Sitbon, A Chaouat… - American journal of …, 2006 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is an orphan disease for which the trend
is for management in designated centers with multidisciplinary teams working in a shared …

Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017)

K Fukuda, H Date, S Doi, Y Fukumoto… - Circulation …, 2019 - jstage.jst.go.jp
Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …

Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic …

X Jaïs, AM D'Armini, P Jansa, A Torbicki… - Journal of the American …, 2008 - jacc.org
Objectives: Our goal was to investigate the effect of treatment with the oral dual endothelin
receptor antagonist bosentan on the hemodynamics and exercise capacity of patients with …

The role of the right ventricle in pulmonary arterial hypertension

AV Noordegraaf, N Galiè - European Respiratory Review, 2011 - Eur Respiratory Soc
Although changes in the pulmonary vasculature are the primary cause of pulmonary arterial
hypertension (PAH), severity of symptoms and survival are strongly associated with right …